Health
CanSino to start Phase III trial of COVID-19 vaccine in Saudi – Marketscreener.com
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
… | August 9, 2020
DUBAI, Aug 9 (Reuters) – Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in
talks with Russia, Brazil, Chile and Saudi Arabia to launch a
Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus
type-5 (Ad5) to carry genetic material fro…
-
Business14 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News19 hours ago28 years later: Grim reality for single house hunters revealed
-
Noosa News14 hours agoDangerous driving charges, Maroochydore – Sunshine Coast
-
General22 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter